GlaxoSmithKline: Not a well prepared quarterly report in our view

NEUTRAL, Fair Value 1810p vs. 1870p (+15%)

News published on October Thursday 24, 2013
Share on

In our view communication around these quarterly numbers has not worked well. Accounting changes for post-retirement medical obligations have created swings in earnings for more than a year now but GSK has failed to provide a clear view about how this could play out at least on an annual basis. In Q3, these changes played a very positive a role but also gave the impression they were artificially offsetting an underlying business that was well below estimates and could also create doubts about guidance. This also diverts attention from key topics which is unfortunate since we see significant growth ahead.

Full report available to subscribers
Please contact  

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities